Education
About Us
Working with TipRanks
Follow Us
Zenas BioPharma, Inc. (ZBIO)
NASDAQ:ZBIO
| Dec 24 | Dec 23 | Dec 22 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | $ 5.00M | $ 50.00M | $ 0.00 |
| Gross Profit | $ -134.14M | $ 50.00M | $ -61.69M |
| Operating Income | $ -163.89M | $ -37.15M | $ -76.20M |
| EBITDA | $ -163.75M | $ -27.03M | $ -75.12M |
| Net Income | $ -156.99M | $ -37.12M | $ -119.28M |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ 350.77M | $ 56.86M | $ 67.21M |
| Total Assets | $ 369.97M | $ 68.18M | $ 74.58M |
| Total Debt | $ 1.00M | $ 21.11M | $ 1.53M |
| Net Debt | $ -318.74M | $ -35.74M | $ -65.68M |
| Total Liabilities | $ 57.51M | $ 293.90M | $ 266.87M |
| Stockholders' Equity | $ 312.46M | $ -225.72M | $ -192.29M |
| Cash Flow | |||
| Free Cash Flow | $ -119.81M | $ -30.55M | $ -67.85M |
| Operating Cash Flow | $ -119.67M | $ -30.53M | $ -65.65M |
| Investing Cash Flow | $ -30.55M | $ -17.00K | $ -2.20M |
| Financing Cash Flow | $ 412.96M | $ 20.12M | $ 59.39M |